posted on Aug, 31 2014 @ 03:19 PM
I really wish this thread had more exposure, it should have been a 200 pager by now. Not just the gory reports in thread on how many people are dead
When you follow the money it creates a very strong case that the outbreak was possibly manufactured. Your basic Supply and Demand scenario. In
circumstances where there is billions to be made and thousands of lives to be lost then amazingly saved at a price, I'm afraid I don't believe in
I saw this article back in 2012. Where these companies funding was pulled by the DOD due to the lack of ability for Big Pharma to make money off a
disease that is contained and inability to spread effectively like an influenza.
funding pulled by Dod for Tekmira and Sarepta.
"But in recent days, both companies have been told by the Defense Department to temporarily stop work on their vaccines due to funding constraints. "
Their stock evaulation back then:
'There isn't a huge customer base and big pharma is obviously interested in big profits. So these niche products which are important for biodefence
are really driven by small companies."
This uncertainty over funding and the absence of interest from large pharmaceutical firms is leading some scientists to argue that a preventative
vaccine might never see the light of day.'
Funding is pulled then miraculously 18 months later -a never-before-seen outbreak.
In Feb/Mar of 2014 another miracle....FAST track granted.
e FDA released the following in an email statement:
"The FDA is also working with U.S. government agencies that fund medical product development and product sponsors to facilitate the development of and
access to medical products that could potentially be used to mitigate Ebola. For example, the FDA granted Fast Track Designation to an investigational
anti-Ebola therapeutic being developed with support from the U.S. Department of Defense in March 2014
The DOD. NIH, FDA approval for Tekmira to Fast track the process process designed to facilitate the development and expedite the review of drugs to
treat serious conditions and fill an unmet medical need.
TKM stocks are up over 100% and Big Pharma are looking to buy them, when only 18 months ago there was np interested and funding pulled.
Now they are evaluated as a great stock buy.
'• TKM-Ebola has attributes that make it the best positioned drug that could potentially be stockpiled by the US Department of Defense as a medical
countermeasure against the Ebola virus.
• By securing a stockpiling contract, Tekmira could receive annual cash flows of $75 million allowing Tekmira to fund their operations and potential
blockbuster candidates such as TKM-HBV via non-dilutive means.'
Of course its in their interest to see Ebola make it to the US and Europe, why do you think they were offered the vaccine? We help early on. now We
have none left...ooops
edit on 31-8-2014 by zazzafrazz because: (no reason given)